Terazosin hydrochloride dihydrate

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

Terazosin HCl 是一种选择性 α1-肾上腺素受体拮抗剂，用于治疗前列腺肥大 (BPH) 的症状。

Terazosin HCl is a selective α1-adrenoceptor antagonist, used for treatment of symptoms of an enlarged prostate (BPH).(In Vitro):Terazosin does not discriminate cloned α1-adrenoceptor subtypes transiently expressed in COS cells.(In Vivo):Terazosin can be used to promote stone discharge in treatment of ureteral stones. Terazosin is reportedly safe and effective in treatment of distal ureteral stones, especially stones >5 mm.

Terazosin does not discriminate cloned α1-adrenoceptor subtypes transiently expressed in COS cells.

Terazosin can be used to promote stone discharge in treatment of ureteral stones. Terazosin is reportedly safe and effective in treatment of distal ureteral stones, especially stones >5 mm.

——

Others

Other Targets

α1-adrenoceptor

Endocrinology

——

70024-40-7

459.92

C19H25N5O4·HCl·2H2O

>98% (HPLC)

DMSO : 50 mg/mL 108.71 mM; H2O : 12.5 mg/mL 27.18 mM

O.O.Cl.COC1=CC2=C(C=C1OC)C(N)=NC(=N2)N1CCN(CC1)C(=O)C1CCCO1

——

(-20℃)

With Ice Pack

≥ 2 years